Fused heterocyclic compounds useful as inhibitors of histone deacetylase
Details for Australian Patent Application No. 2006214319 (hide)
International Classifications
Event Publications
23 August 2007 PCT application entered the National Phase
PCT publication WO2006/088949 Priority application(s): WO2006/088949
6 January 2011 Corrigenda
PCT applications that have entered the National Phase - Name Index Under the name Mikana Therapeutics, Inc., Application No. 2006214319, under INID (71) correct the applicant name to Miikana Therapeutics, Inc.
6 September 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2006214320-Methods and reagents for treatment and diagnosis of age-related macular degeneration
2006214317-Methods and apparatus for machineto-machine communications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser